Identifying blood markers for Valley Fever
Serological Biomarkers for Coccidioidomycosis
This study is working on creating better blood tests to help doctors find Valley Fever, especially in older patients who might have it but currently test negative, so they can get the right treatment sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10844516 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis of coccidioidomycosis, commonly known as Valley Fever, which is particularly prevalent in southern Arizona and California. The study aims to develop more sensitive and specific serological tests to detect the presence of the Coccidioides fungus in patients, especially among the elderly who are at higher risk. By analyzing blood samples, the researchers hope to identify biomarkers that can accurately indicate infection, even in patients who currently test negative but are symptomatic. This could lead to timely and appropriate treatment for those affected by this serious illness.
Who could benefit from this research
Good fit: Ideal candidates for this research include elderly individuals living in or visiting areas where Valley Fever is common, particularly those showing symptoms of respiratory illness.
Not a fit: Patients who do not reside in or travel to endemic areas for Valley Fever may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of Valley Fever, improving patient outcomes and treatment options.
How similar studies have performed: Previous research has indicated the need for improved diagnostic methods for Valley Fever, suggesting that this approach could yield significant advancements in patient care.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Magee, D Mitchell — Arizona State University-Tempe Campus
- Study coordinator: Magee, D Mitchell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.